Chimerix
Chimerix is a North Carolina-based biopharmaceutical company that develops and commercializes antiviral therapies for the treatment of smallpox and cancer.
Business Model:
Revenue: $33.1M
Employees: 51-200
Industries / Tags:
Detailed Chimerix Information
Geographic Data
Address: 2505 Meridian Parkway
City: Durham
State: NC
Zip: 27713
Country: US
Financial Info
Stage:
post ipo debt
Raised Last:
$50M
Raised Total:$325M
Social
Metrics
54,575Website Global Rank
1,927,716Website Monthly Traffic
Twitter Followers
Description
Chimerix is a North Carolina-based biopharmaceutical company that develops and commercializes antiviral therapies for the treatment of smallpox and cancer.
Contact Phone:
+19198061074
Contact Email:
Chimerix went public on 4/12/2013 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
4/12/2013
IPO Valuation:
$342M
Ticker Symbol:
CMRX
IPO Price:
$14/share
Amount Raised:
$118M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 1/2021 | Oncoceutics |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
